Elevation of myostatin and FOXOs in prolonged muscular impairment induced by eccentric contractions in rat medial gastrocnemius muscle. 2010

Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
Laboratory of Health and Sports Sciences, Center for Liberal Arts, Meiji Gakuin Univ., 1518 Kamikurata-cho, Totsuka-ku, Yokohama, Kanagawa 244-8539, Japan. ochi@gen.meijigakuin.ac.jp

This study aimed to investigate torque deficit and activation of protein synthesis and/or protein degradation signaling pathways during the early and recovery phase after high- and low-velocity eccentric contractions (ECs). Male Wistar rats (n = 36) were randomly divided into fast angular velocity ECs group (FAST; 180 degrees/s; n = 12), slow ECs group (SLOW; 30 degrees/s; n = 12), and control group (control; n = 12). ECs comprised four sets of five forced dorsiflexions combined with electrical stimulation of the plantar flexors. Isometric tetanic torque was measured before and after ECs. Tissue contents of Akt(P) (P, phosphorylated), mammalian target of rapamycin (mTOR)(P), 70-kDa ribosomal protein S6 kinase (P70S6k), P70S6k(P), forkhead transcription factor 1 of the O class (FOXO1), FOXO1(P), FOXO3, FOXO3(P), myostatin, and activin receptor type IIB (ActRIIB) were measured. The isometric tetanic torque after ECs was significantly lower in FAST than in SLOW (days 1, 3, and 5, P < 0.05; day 2, P < 0.01). The ratio of P70S6k(P) against total P70S6k on days 2 and 7 was significantly higher in SLOW than in the control. The ratio of FOXO1 against total FOXO1, the ratio of FOXO3a against total FOXO3a, and myostatin on days 2 and 7 were significantly higher in FAST than in the control, while that of ActRIIB on day 7 was significantly lower in SLOW than in the other two groups. These results suggest that EC intensity plays a key role in impairment of muscular function and activation of protein synthesis and/or protein degradation signaling pathways.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D007537 Isometric Contraction Muscular contractions characterized by increase in tension without change in length. Contraction, Isometric,Contractions, Isometric,Isometric Contractions
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D000071316 Forkhead Box Protein O3 A forkhead box transcription factor and transcriptional activator which triggers type 1 programmed cell death (APOPTOSIS) in the absence of APOPTOSIS INHIBITING PROTEINS, including neuronal cell death induced by OXIDATIVE STRESS. It recognizes and binds to the DNA sequence 5'-(AG)TAAA(TC)A-3' and also functions in post-transcriptional regulation of the c-MYC PROTO-ONCOGENE. FOXO3 Protein,Forkhead in Rhabdomyosarcoma-Like 1 Protein,Forkhead in Rhabdomyosarcoma Like 1 Protein,Protein, FOXO3

Related Publications

Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
July 2014, Muscle & nerve,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
July 2020, Scientific reports,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
January 1989, The Journal of experimental biology,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
October 1988, Pflugers Archiv : European journal of physiology,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
January 2006, Journal of sports science & medicine,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
June 1991, Journal of applied physiology (Bethesda, Md. : 1985),
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
November 2000, European journal of applied physiology,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
October 2015, Journal of muscle research and cell motility,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
November 2003, Pflugers Archiv : European journal of physiology,
Eisuke Ochi, and Tatsuro Hirose, and Kenji Hiranuma, and Seok-Ki Min, and Naokata Ishii, and Koichi Nakazato
March 2023, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!